TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31188779

Group type: EXPERIMENTAL
Intervention: Rational-Emotive Behavior Therapy (REBT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30
Study: 28858362

Group type: EXPERIMENTAL
Intervention: Caffeinated coffee (18 g containing 300 mg CGA in 200 mL hot water)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Decaffeinated coffee (18 g containing 287 mg CGA in 200 mL hot water)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Hot water (control)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Caffeinated coffee, decaffeinated coffee, and hot water (control)
Number of subjects: 12
Study: 25944073

Group type: EXPERIMENTAL
Intervention: DEX with on-demand MDZ
Number of subjects: 80

Group type: COMPARATOR
Intervention: MDZ alone
Number of subjects: 80
Study: 22127508

Group type: EXPERIMENTAL
Intervention: Serum level of under-carboxylated osteocalcin (ucOC)
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Serum ucOC expressed as percentage of total osteocalcin level
Number of subjects: 334
Study: 21282825

Group type: EXPERIMENTAL
Intervention: AS03(A)-adjuvanted H5N1 vaccine (3.75 microgram H5N1 haemagglutinin + AS03(A))
Number of subjects: 360

Group type: COMPARATOR
Intervention: Non-adjuvanted H5N1 vaccine (3.75 microgram H5N1)
Number of subjects: 360
Study: 19375519

Group type: EXPERIMENTAL
Intervention: Oral mesalamine 2 g once daily
Number of subjects: 362

Group type: COMPARATOR
Intervention: Oral mesalamine 1 g twice daily
Number of subjects: 362

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 362
Study: 16391575

Group type: EXPERIMENTAL
Intervention: Calcium (1 g) and Vitamin D3 (800 IU) supplementation once daily for 1 year
Number of subjects: 23

Group type: COMPARATOR
Intervention: No supplementation (Control group)
Number of subjects: 23
Study: 12633544

Group type: EXPERIMENTAL
Intervention: Direct stenting
Number of subjects: 400

Group type: COMPARATOR
Intervention: Stenting preceded by balloon predilatation
Number of subjects: 400
Study: 10842553

Group type: COMPARATOR
Intervention: Daily iron/folate supplement (60 mg iron/0.25 mg folate per day)
Number of subjects: 413

Group type: EXPERIMENTAL
Intervention: Weekly iron/folate supplement (120 mg iron/0.50 mg folate once a week)
Number of subjects: 413
Study: 9378838

Group type: EXPERIMENTAL
Intervention: Treatment A
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment B
Number of subjects: 0
Study: 8518219

Group type: EXPERIMENTAL
Intervention: MPA (medroxyprogesterone acetate) 500 mg i.m. daily for 28 days, then 500 mg i.m. twice weekly for 5 months
Number of subjects: 408

Group type: EXPERIMENTAL
Intervention: MPA (medroxyprogesterone acetate)
Number of subjects: 408

Group type: EXPERIMENTAL
Intervention: MPA+ group
Number of subjects: 408

Group type: COMPARATOR
Intervention: MPA- group
Number of subjects: 408
Study: 3830118

Group type: EXPERIMENTAL
Intervention: Caffeine (3.3 mg/kg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 29446548

Group type: EXPERIMENTAL
Intervention: 12-h combined physical and psychological treatment programme
Number of subjects: 373
Study: 27530188

Group type: EXPERIMENTAL
Intervention: Ketoconazole 400 mg once daily for 7 days, edoxaban on day 4
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Erythromycin 500 mg four times daily for 8 days, edoxaban on day 7
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Cyclosporine 500 mg single dose with edoxaban
Number of subjects: 3

Group type: COMPARATOR
Intervention: Edoxaban alone
Number of subjects: 3
Study: 24460597

Group type: EXPERIMENTAL
Intervention: Orientated tour with mother of the operation room the night before surgery
Number of subjects: 70

Group type: COMPARATOR
Intervention: Standard preoperative care (Control)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Orientated tour (Intervention)
Number of subjects: 70
Study: 23286674

Group type: EXPERIMENTAL
Intervention: Education program via surface mail providing information on influenza vaccine effectiveness and safety (EPG)
Number of subjects: 2402

Group type: COMPARATOR
Intervention: No intervention (NPG)
Number of subjects: 2402

Group type: EXPERIMENTAL
Intervention: Education program via surface mail (EPG)
Number of subjects: 2402
Study: 20636229

Group type: EXPERIMENTAL
Intervention: Interval training (n=39)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control group (n=39)
Number of subjects: 78
Study: 18300707

Group type: EXPERIMENTAL
Intervention: Muller maneuver (MM) with videoendoscopy
Number of subjects: 70
Study: 16336797

Group type: EXPERIMENTAL
Intervention: Fibrin glue (10 ml) applied at the end of breast resection plus closed suction drains
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (drain system only)
Number of subjects: 43
Study: 12827575

Group type: COMPARATOR
Intervention: General anesthesia (GA) with fentanyl, propofol, rocuronium (n = 37)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Thoracic epidural anesthesia with meperidine (TEA-M) (2 mg/kg in 10-12 mL) (n = 35)
Number of subjects: 72
Study: 10583037

Group type: EXPERIMENTAL
Intervention: Fenoterol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fenoterol plus losartan
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (electrolyte solution)
Number of subjects: 0
Study: 8722359

Group type: EXPERIMENTAL
Intervention: Pre-emptive antiviral therapy with ganciclovir
Number of subjects: 58

Group type: COMPARATOR
Intervention: Matched historical controls
Number of subjects: 58
Study: 1725620

Group type: EXPERIMENTAL
Intervention: Platelet concentrates from AS-104
Number of subjects: 115

Group type: COMPARATOR
Intervention: Platelet concentrates from CS-3000
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Platelet concentrates from AS-104 stored in teflon bags
Number of subjects: 115

Group type: COMPARATOR
Intervention: Platelet concentrates from CS-3000 stored in polyolefine bags
Number of subjects: 115
Study: 7074650

Group type: EXPERIMENTAL
Intervention: Radiotherapy (RT) to supradiaphragmatic and infradiaphragmatic lymph node regions (total nodal irradiation)
Number of subjects: 261

Group type: COMPARATOR
Intervention: RT plus chemotherapy (CT)
Number of subjects: 261
Study: 30007330

Group type: EXPERIMENTAL
Intervention: 0.018-inch slot bracket system
Number of subjects: 187

Group type: COMPARATOR
Intervention: 0.022-inch slot bracket system
Number of subjects: 187
Study: 28443790

Group type: EXPERIMENTAL
Intervention: Pilates-based exercises along with standard exercise program
Number of subjects: 46

Group type: COMPARATOR
Intervention: Standard exercise program
Number of subjects: 46
Study: 26598115

Group type: EXPERIMENTAL
Intervention: Endovascular repair (EVAR)
Number of subjects: 881
Study: 24337434

Group type: EXPERIMENTAL
Intervention: Jumbo forceps biopsy (8 mm); 4 endoscopic forceps biopsy specimens obtained.
Number of subjects: 148

Group type: COMPARATOR
Intervention: Conventional forceps biopsy (6.8 mm); 4 endoscopic forceps biopsy specimens obtained.
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Increasing the number of biopsies (2 or 4 EFBs); analyzed for concordance rate.
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: High grade dysplasia analysis; evaluated in both groups.
Number of subjects: 148
Study: 21412218

Group type: EXPERIMENTAL
Intervention: Low-AGE diet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alagebrium treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: High-AGE diet
Number of subjects: 0
Study: 19643487

Group type: EXPERIMENTAL
Intervention: GS-101 eye drops (86 microg/day)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: GS-101 eye drops (43 microg/day)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: GS-101 eye drops (172 microg/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 17584213

Group type: EXPERIMENTAL
Intervention: Cochrane Highly Sensitive Search Strategy (HSSS) terms
Number of subjects: 285
Study: 15105664

Group type: EXPERIMENTAL
Intervention: 100% effort group
Number of subjects: 90

Group type: COMPARATOR
Intervention: 60% effort group
Number of subjects: 90
Study: 11903179

Group type: EXPERIMENTAL
Intervention: Gadoteridol (0.1 mmol/kg)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Gadopentetate dimeglumine (0.1 mmol/kg)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Gadoteridol
Number of subjects: 92

Group type: COMPARATOR
Intervention: Gadopentetate dimeglumine
Number of subjects: 92
Study: 9177871

Group type: EXPERIMENTAL
Intervention: 0.75 microgram of 1‐alpha‐hydroxyvitamin D3 with calcium (150 mg/day)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Calcium only (control group)
Number of subjects: 50
Study: 7954417

Group type: EXPERIMENTAL
Intervention: Vorozole 1 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Vorozole 2.5 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Vorozole 5 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Vorozole (all doses)
Number of subjects: 24
Study: 3300966

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Combination of tamoxifen and fluoxymesterone
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (no adjuvant endocrine therapy)
Number of subjects: 54
Study: 31639370

Group type: EXPERIMENTAL
Intervention: Vaginal delivery
Number of subjects: 14335

Group type: COMPARATOR
Intervention: Cesarean section
Number of subjects: 14335

Group type: COMPARATOR
Intervention: Nulliparous women
Number of subjects: 14335
Study: 29452815

Group type: EXPERIMENTAL
Intervention: Controlled Variable Ventilation (CVV)
Number of subjects: 50
Study: 26636424

Group type: EXPERIMENTAL
Intervention: Low glycemic index (≤45) with low percentage of carbohydrates (40% kcal)
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Low glycemic index with high percentage of carbohydrates
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Combined effect of lowering glycemic index and increasing percentage of carbohydrates
Number of subjects: 163

Group type: COMPARATOR
Intervention: High glycemic index (≥65) with high percentage of carbohydrates (58% kcal)
Number of subjects: 163
Study: 24743493

Group type: EXPERIMENTAL
Intervention: Online post-dilution hemodiafiltration (HDF)
Number of subjects: 714

Group type: COMPARATOR
Intervention: Low-flux hemodialysis (HD)
Number of subjects: 714
Study: 22577809

Group type: EXPERIMENTAL
Intervention: Single-site laparoscopic appendectomy
Number of subjects: 360

Group type: COMPARATOR
Intervention: Three-port laparoscopic appendectomy
Number of subjects: 360
Study: 20929123

Group type: EXPERIMENTAL
Intervention: Chinese medicine for nourishing yin and clearing heat therapy (CM therapy)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard Western medical therapy
Number of subjects: 60
Study: 18512767

Group type: EXPERIMENTAL
Intervention: CAG repeat length (CAGn)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Age adjustment
Number of subjects: 0
Study: 16459897

Group type: EXPERIMENTAL
Intervention: Younger adults
Number of subjects: 2

Group type: COMPARATOR
Intervention: Older adults
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Easy problems
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Hard problems
Number of subjects: 2
Study: 14530064

Group type: EXPERIMENTAL
Intervention: Cardiac surgical procedures in African Americans
Number of subjects: 0
Study: 10392729

Group type: EXPERIMENTAL
Intervention: Intravitreal tissue plasminogen activator (tPA) 65-110 microg
Number of subjects: 26
Study: 8704358

Group type: EXPERIMENTAL
Intervention: MFP-Ca (100 mg sodium monofluorophosphate + 500.5 mg Ca2+)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Ca tablet (500.5 mg Ca2+)
Number of subjects: 35
Study: 2054405

Group type: EXPERIMENTAL
Intervention: Small cuff
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Large cuff
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Appropriate cuff
Number of subjects: 181
Study: 6341904

Group type: EXPERIMENTAL
Intervention: Trimethoprim (300 mg daily)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Co-trimoxazole (0.96 g 12-hourly)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sulphamethizole (1 g eight-hourly)
Number of subjects: 60
Study: 30605952

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy for insomnia (CBT-i)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Combination of CBT-i with tapered hypnotic agents
Number of subjects: 75
Study: 29680779

Group type: EXPERIMENTAL
Intervention: Localized vibration on quadriceps tendon
Number of subjects: 28

Group type: COMPARATOR
Intervention: No vibration (control condition)
Number of subjects: 28
Study: 26666448

Group type: EXPERIMENTAL
Intervention: Early Asthma Education Intervention (EI) for 12 months
Number of subjects: 10

Group type: COMPARATOR
Intervention: Delayed Asthma Education Intervention (DI) after 12 months observation
Number of subjects: 10
Study: 24446385

Group type: EXPERIMENTAL
Intervention: Exogenous insulin (biphasic insulin aspart) administered in relation to meals
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Circadian rhythm included in the model
Number of subjects: 0
Study: 22129890

Group type: EXPERIMENTAL
Intervention: Siltuximab plus mitoxantrone/prednisone (M/P)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Mitoxantrone/prednisone (M/P) alone
Number of subjects: 97
Study: 20170477

Group type: EXPERIMENTAL
Intervention: artesunate-amodiaquine (AS-AQ)
Number of subjects: 1401

Group type: EXPERIMENTAL
Intervention: artesunate-sulphadoxine-pyrimethamine (AS-SP)
Number of subjects: 1401

Group type: EXPERIMENTAL
Intervention: artesunate-chlorproguanil-dapsone (AS-CD)
Number of subjects: 1401

Group type: EXPERIMENTAL
Intervention: artesunate-mefloquine (AS-MQ)
Number of subjects: 1401

Group type: EXPERIMENTAL
Intervention: dihydroartemisinin-piperaquine (DH-PP)
Number of subjects: 1401

Group type: EXPERIMENTAL
Intervention: artemether-lumefantrine (AM-LM)
Number of subjects: 1401

Group type: EXPERIMENTAL
Intervention: amodiaquine
Number of subjects: 1401

Group type: EXPERIMENTAL
Intervention: amodiaquine-sulphadoxine-pyrimethamine (AQ-SP)
Number of subjects: 1401
Study: 17638699

Group type: EXPERIMENTAL
Intervention: 75 mg bevirimat
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 150 mg bevirimat
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 250 mg bevirimat
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 15868998

Group type: EXPERIMENTAL
Intervention: Alfentanil 10 microg/kg at 5 min before intubation
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Alfentanil 10 microg/kg at 3 min before intubation
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Alfentanil 10 microg/kg at 1 min before intubation
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Alfentanil 10 microg/kg at 0.5 min before intubation
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Alfentanil 10 microg/kg at 5, 3, 1, and 0.5 min before intubation
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo (normal saline 2 ml just before induction)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Alfentanil 10 microg/kg at 1 and 3 min before intubation
Number of subjects: 75
Study: 12774058

Group type: COMPARATOR
Intervention: 10% DMSO
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: 5% DMSO/6% HES
Number of subjects: 294
Study: 10563609

Group type: EXPERIMENTAL
Intervention: Total Neuropathy Score (TNS)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Mayo Clinic measures of neuropathy, Neuropathy Symptom Score (NSS), Neurologic Impairment Score (NIS)
Number of subjects: 35
Study: 8531545

Group type: EXPERIMENTAL
Intervention: Pyronaridine 32 mg/kg, orally divided over 3 days
Number of subjects: 96

Group type: COMPARATOR
Intervention: Chloroquine 25 mg/kg, orally divided over 3 days
Number of subjects: 96
Study: 1857645

Group type: EXPERIMENTAL
Intervention: Injections in the abdomen
Number of subjects: 101

Group type: COMPARATOR
Intervention: Injections in the thigh
Number of subjects: 101

Group type: COMPARATOR
Intervention: Injections in the arm
Number of subjects: 101
Study: 6418506

Group type: EXPERIMENTAL
Intervention: saline lavage solutions similar to plasma
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: mannitol solution
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: hypertonic salt and mannitol solution (415 mosmol/l)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: isotonic saline mannitol solution with 105 mmol/l sodium, 93 mmol/l chloride, 10 mmol/l potassium and 22 mmol/l bicarbonate as well as 70 mmol/l mannitol (or 70 mmol/l polyethylene glycol)
Number of subjects: 64
Study: 29444538

Group type: EXPERIMENTAL
Intervention: Judo-specific resistance training program using a judo ergometer system (PTJ)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Traditional resistance training regime using a partner (PTP)
Number of subjects: 24
Study: 27111089

Group type: EXPERIMENTAL
Intervention: Abatacept (125 mg every week)
Number of subjects: 646

Group type: COMPARATOR
Intervention: Adalimumab (40 mg every 2 weeks)
Number of subjects: 646
Study: 25768709

Group type: EXPERIMENTAL
Intervention: Counselling + Occlusal Splints (Group 2)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Counselling (Group 1)
Number of subjects: 60
Study: 23063624

Group type: EXPERIMENTAL
Intervention: Home-based functional exercises (twice-weekly 60-minute sessions for 6 months)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Advice to stay active (control group)
Number of subjects: 110
Study: 20119976

Group type: EXPERIMENTAL
Intervention: Laparoscopy
Number of subjects: 34

Group type: COMPARATOR
Intervention: Laparotomy
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 34
Study: 18661191

Group type: EXPERIMENTAL
Intervention: General internists providing primary care for adults with cystic fibrosis (CF)
Number of subjects: 1288

Group type: EXPERIMENTAL
Intervention: General internists providing primary care for adults with sickle cell disease (SCD)
Number of subjects: 1288

Group type: EXPERIMENTAL
Intervention: Pediatricians providing primary care for adults with cystic fibrosis (CF)
Number of subjects: 1288

Group type: EXPERIMENTAL
Intervention: Pediatricians providing primary care for adults with sickle cell disease (SCD)
Number of subjects: 1288
Study: 17242102

Group type: EXPERIMENTAL
Intervention: Granisetron 3 mg IV
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Ondansetron 8 mg IV
Number of subjects: 129

Group type: COMPARATOR
Intervention: Saline IV
Number of subjects: 129
Study: 12562649

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (ICT) and adjuvant chemotherapy (ACT) every 2 weeks with granulocyte-macrophage colony-stimulating factor (GM-CSF) support (arm B, 'dose-dense treatment')
Number of subjects: 150

Group type: COMPARATOR
Intervention: Induction chemotherapy (ICT) and adjuvant chemotherapy (ACT) every 3 weeks (arm A, 'standard treatment')
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Both arms received three courses of CEF followed by local therapy and three courses of CEF alternated with three courses of CMF.
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Dose intensity of chemotherapy in arm B
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Duration of treatment in arm B
Number of subjects: 150

Group type: COMPARATOR
Intervention: Duration of treatment in arm A
Number of subjects: 150
Study: 10880550

Group type: EXPERIMENTAL
Intervention: Paclitaxel plus supportive care
Number of subjects: 157

Group type: COMPARATOR
Intervention: Supportive care alone
Number of subjects: 157
Study: 8838831

Group type: EXPERIMENTAL
Intervention: Enteral nutrition (TEN)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Total parenteral nutrition (TPN)
Number of subjects: 34
Study: 1296898

Group type: EXPERIMENTAL
Intervention: Hands-on foot care teaching/learning approach
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lecture presentation on foot care (Control)
Number of subjects: 0
Study: 6372986

Group type: EXPERIMENTAL
Intervention: Scalp hypothermia
Number of subjects: 26

Group type: COMPARATOR
Intervention: Chemotherapy alone (Control)
Number of subjects: 26
Study: 31232991

Group type: EXPERIMENTAL
Intervention: CAD/CAM with drilling guiding templates and pre-bent titanium plates
Number of subjects: 24

Group type: COMPARATOR
Intervention: CAD/CAM occlusal splints only
Number of subjects: 24
Study: 29966130

Group type: EXPERIMENTAL
Intervention: Nutritional training and lifestyle exercise intervention for 12 months
Number of subjects: 141

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 141
Study: 26675765

Group type: EXPERIMENTAL
Intervention: Selenium supplementation at 60 μg/d
Number of subjects: 227

Group type: COMPARATOR
Intervention: No supplementation
Number of subjects: 227
Study: 24648722

Group type: EXPERIMENTAL
Intervention: Excessive daytime sleepiness (EDS) defined by Epworth Sleepiness Scale (cutoff score ≥10)
Number of subjects: 1058

Group type: EXPERIMENTAL
Intervention: Excessive daytime sleepiness (EDS)
Number of subjects: 1058
Study: 22245713

Group type: EXPERIMENTAL
Intervention: Intervention to improve opioid compliance in high-risk group
Number of subjects: 62

Group type: COMPARATOR
Intervention: High-risk control group
Number of subjects: 62
Study: 19085680

Group type: EXPERIMENTAL
Intervention: Prepregnancy BMI
Number of subjects: 841

Group type: EXPERIMENTAL
Intervention: Prepregnancy BMI (after removing large-for-gestational-age infants)
Number of subjects: 841

Group type: EXPERIMENTAL
Intervention: Weight gain
Number of subjects: 841
Study: 17901735

Group type: EXPERIMENTAL
Intervention: liposome polyvinyl‐pyrrolidone‐iodine (PVP‐I) hydrogel
Number of subjects: 43

Group type: COMPARATOR
Intervention: silver‐sulfadiazine cream
Number of subjects: 43
Study: 15228362

Group type: EXPERIMENTAL
Intervention: NPT strategy using naphthoquinone with physiological thiols for measuring plasma thiol concentrations
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard techniques for corroborating results
Number of subjects: 0
Study: 12407041

Group type: EXPERIMENTAL
Intervention: 150 micro g desogestrel with testosterone pellets
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: 300 micro g desogestrel with testosterone pellets
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: 150 micro g and 300 micro g desogestrel with testosterone pellets
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Combination of oral desogestrel with depot testosterone
Number of subjects: 31
Study: 9696231

Group type: EXPERIMENTAL
Intervention: Detection of BAK protein by immunohistochemical and immunoblot analyses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Immunoblot analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Detection of apoptosis by in situ DNA end-labeling
Number of subjects: 0